New findings in osteoarthritis pathogenesis: Therapeutic implications

Therapeutic Advances in Chronic Disease

Volumn 4, Issue 1, 2013, Pages 23-43

  Meliconi, Riccardo ^a   Pulsatelli, Lia ^a   Addimanda, Olga ^a   Brusi, Veronica ^a   Pavloska, Branka ^a  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Articular cartilage; New treatments; Osteoarthritis; Signaling pathways

Indexed keywords

ADALIMUMAB; ADENOSINE A3 RECEPTOR AGONIST; AGGRECANASE INHIBITOR; AMG 108; BETA CATENIN; BONE MORPHOGENETIC PROTEIN; CANAKINUMAB; DISCOIDIN DOMAIN RECEPTOR 2; ENZYME INHIBITOR; FIBROBLAST GROWTH FACTOR 18; FRIZZLED PROTEIN; HYPOXIA INDUCIBLE FACTOR; I KAPPA B KINASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; MONOCLONAL ANTIBODY; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOGENIC PROTEIN 1; PH 797804; PROTEINASE INHIBITOR; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RILONACEPT; SONIC HEDGEHOG PROTEIN; SYNDECAN 4; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; WNT PROTEIN;

BONE CELL; CARTILAGE; HAND OSTEOARTHRITIS; HUMAN; KNEE OSTEOARTHRITIS; MOLECULAR BIOLOGY; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

EID: 84875665620     PISSN: 20406223     EISSN: 20406231     Source Type: Journal    
DOI: 10.1177/2040622312462734     Document Type: Review

References (200)

1. Abramson S. (1999) The role of COX-2 produced by cartilage in arthritis. Osteoarthritis Cartilage 7: 380–381.
2. Abramson S. (2008) Osteoarthritis and nitric oxide. Osteoarthritis Cartilage 16(Suppl. 2): S15–S20.
3. Aigner T. Fundel K. Saas J. Gebhard P. Haag J. Weiss T. et al. (2006) Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. Arthritis Rheum 54: 3533–3544.
4. Aigner T. Zien A. Gehrsitz A. Gebhard P. McKenna L. (2001) Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 44: 2777–2789.
5. Alvarez J. Serra R. (2004) Unique and redundant roles of SMAD 3 in TGF-beta-mediated regulation of long bone development in organ culture. Dev Dyn 230: 685–699.
6. Attur M. Al-Mussawir H. Patel J. Kitay A. Dave M. Palmer G. et al. (2008) Prostaglandin E 2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP 4 receptor. J Immunol 181: 5082–5088.
7. Austin R. (2009) The unfolded protein response in health and disease. Antioxid Redox Signal 11: 2279–2287.
8. Bacconnier L. Jorgensen C. Fabre S. (2009) Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 68: 1078–1079.
9. Barley R. Adesida A. Bagnall K. Jomha N. (2010) Immunohistochemical characterization of reparative tissue present in human osteoarthritic tissue. Virchows Arch 456: 561–569.
10. Barre P. Redini F. Boumediene K. Vielpeau C. Pujol J. (2000) Semiquantitative reverse transcription-polymerase chain reaction analysis of syndecan-1 and -4 messages in cartilage and cultured chondrocytes from osteoarthritic joints. Osteoarthritis Cartilage 8: 34–43.
11. Bar-Yehuda S. Rath-Wolfson L. Del Valle L. Ochaion A. Cohen S. Patoka R. et al. (2009) Induction of an Antiinflammatory Effect and Prevention of Cartilage Damage in Rat Knee Osteoarthritis by Cf 101 Treatment. Arthritis Rheum 60: 3061–3071.
12. Bertrand J. Cromme C. Umlauf D. Frank S. Pap T. (2010) Molecular mechanisms of cartilage remodelling in osteoarthritis. Int J Biochem Cell Biol 42: 1594–1601.
13. Blaney Davidson E. Remst D. Vitters E. van Beuningen H. Blom A. Goumans M. et al. (2009) Increase in Alk1/Alk5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice. J Immunol 182: 7937–7945.
14. Blaney Davidson E. Vitters E. van Beuningen H. van de Loo F. van Den Berg W. van der Kraan P. (2007) Resemblance of osteophytes in experimental osteoarthritis to transforming growth factor beta-induced osteophytes: limited role of bone morphogenetic protein in early osteoarthritic osteophyte formation. Arthritis Rheum 56: 4065–4073.
15. Blaney Davidson E. Vitters E. van Den Berg W. van der Kraan P. (2006) TGF beta-induced cartilage repair is maintained but fibrosis is blocked in the presence of Smad7. Arthritis Res Ther 8: R65.
16. Blaney Davidson E. Vitters E. van der Kraan P. van Den Berg W. (2006) Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule Smad-2p in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann Rheum Dis 65: 1414–1421.
17. Bobacz K. Sunk I. Hofstaetter J. Amoyo L. Toma C. Akira S. et al. (2007) Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7. Arthritis Rheum 56: 1880–1893.
18. Bohensky J. Terkhorn S. Freeman T. Adams C. Garcia J. Shapiro I. et al. (2009) Regulation of autophagy in human and murine cartilage: hypoxia-inducible factor 2 suppresses chondrocyte autophagy. Arthritis Rheum 60: 1406–1415.
19. Borzi R. Mazzetti I. Marcu K. Facchini A. (2004) Chemokines in cartilage degradation. Clin Orthop Relat Res (427 Suppl.): S53–S61.
20. Brandt K. Mazzuca S. (2006) Experience with a placebo-controlled randomized clinical trial of a disease-modifying drug for osteoarthritis: The Doxycycline Trial. Rheum Dis Clin North Am 32: 217–234, xi–xii.
21. Brew C. Clegg P. Boot-Handford R. Andrew J. Hardingham T. (2010) Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy. Ann Rheum Dis 69: 234–240.
22. Cawston T. Wilson A. (2006) Understanding the role of tissue degrading enzymes and their inhibitors in development and disease. Best Pract Res Clin Rheumatol 20: 983–1002.
23. Chang H. Shyu K. Wang B. Kuan P. (2003) Regulation of hypoxia-inducible factor-1alpha by cyclical mechanical stretch in rat vascular smooth muscle cells. Clin Sci (Lond) 105: 447–456.
24. Chao P. Hsieh M. Cheng C. Lin Y. Chen C. (2011) Regulation of MMP-3 expression and secretion by the chemokine eotaxin-1 in human chondrocytes. J Biomed Sci 18: 86.
25. Chen X. Macica C. Nasiri A. Broadus A. (2008) Regulation of articular chondrocyte proliferation and differentiation by Indian Hedgehog and parathyroid hormone-related protein in mice. Arthritis Rheum 58: 3788–3797.
26. Chevalier X. Goupille P. Beaulieu A. Burch F. Bensen W. Conrozier T. et al. (2009) Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 61: 344–352.
27. Chia S. Sawaji Y. Burleigh A. Mclean C. Inglis J. Saklatvala J. et al. (2009) Fibroblast growth factor 2 is an intrinsic chondroprotective agent that suppresses ADAMTS-5 and delays cartilage degradation in murine osteoarthritis. Arthritis Rheum 60: 2019–2027.
28. Chun J. Oh H. Yang S. Park M. (2008) Wnt signaling in cartilage development and degeneration. BMB Rep 41: 485–494.
29. Chung U. Schipani E. McMahon A. Kronenberg H. (2001) Indian Hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J Clin Invest 107: 295–304.
30. Cohen S. Proudman S. Kivitz A. Burch F. Donohue J. Burstein D. et al. (2011) A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 13: R125.
31. Coimbra I. Jimenez S. Hawkins D. Piera-Velazquez S. Stokes D. (2004) Hypoxia inducible factor-1 alpha expression in human normal and osteoarthritic chondrocytes. Osteoarthritis Cartilage 12: 336–345.
32. Corbit K. Aanstad P. Singla V. Norman A. Stainier D. Reiter J. (2005) Vertebrate smoothened functions at the primary cilium. Nature 437: 1018–1021.
33. Davidson D. Blanc A. Filion D. Wang H. Plut P. Pfeffer G. et al. (2005) Fibroblast growth factor (FDF) 18 signals through FGF receptor 3 to promote chondrogenesis. J Biol Chem 280: 20509–20515.
34. Dell'accio F. de Bari C. El Tawil N. Barone F. Mitsiadis T. O'Dowd J. et al. (2006) Activation of Wnt and BMP signaling in adult human articular cartilage following mechanical injury. Arthritis Res Ther 8: R139.
35. Dell'accio F. de Bari C. Eltawil N. Vanhummelen P. Pitzalis C. (2008) Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum 58: 1410–1421.
36. Deng T. Huang S. Zhou S. He L. Jin Y. (2007) Cartilage regeneration using a novel gelatin-chondroitin-hyaluronan hybrid scaffold containing BFGF-impregnated microspheres. J Microencapsul 24: 163–174.
37. de Seny D. Sharif M. Fillet M. Cobraiville G. Meuwis M. Maree R. et al. (2011) Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis. Ann Rheum Dis 70: 1144–1152.
38. Diarra D. Stolina M. Polzer K. Zwerina J. Ominsky M. Dwyer D. et al. (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156–163.
39. Duval E. Leclercq S. Elissalde J. Demoor M. Galera P. Boumediene K. (2009) Hypoxia-inducible factor 1alpha inhibits the fibroblast-like markers type I and type III collagen during hypoxia-induced chondrocyte redifferentiation: hypoxia not only induces type II collagen and aggrecan, but it also inhibits type I and type III collagen in the hypoxia-inducible factor 1alpha-dependent redifferentiation of chondrocytes. Arthritis Rheum 60: 3038–3048.
40. Echtermeyer F. Bertrand J. Dreier R. Meinecke I. Neugebauer K. Fuerst M. et al. (2009) Syndecan-4 regulates ADAMTS-5 activation and cartilage breakdown in osteoarthritis. Nat Med 15: 1072–1076.
41. Ellman M. An H. Muddasani P. Im H. (2008) Biological impact of the fibroblast growth factor family on articular cartilage and intervertebral disc homeostasis. Gene 420: 82–89.
42. Ellsworth J. Berry J. Bukowski T. Claus J. Feldhaus A. Holderman S. et al. (2002) Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthritis Cartilage 10: 308–320.
43. Eltawil N. de Bari C. Achan P. Pitzalis C. Dell'accio F. (2009) A novel in vivo murine model of cartilage regeneration. age and strain-dependent outcome after joint surface injury. Osteoarthritis Cartilage 17: 695–704.
44. Ema M. Taya S. Yokotani N. Sogawa K. Matsuda Y. Fujii-Kuriyama Y. (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci U S A 94: 4273–4278.
45. Fan Z. Chubinskaya S. Rueger D. Bau B. Haag J. Aigner T. (2004) Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein-1. Clin Exp Rheumatol 22: 103–106.
46. Fernandez-Puente P. Mateos J. Fernandez-Costa C. Oreiro N. Fernandez-Lopez C. Ruiz-Romero C. et al. (2011) Identification of a panel of novel serum osteoarthritis biomarkers. J Proteome Res 10: 5095–5101.
47. Finnson K. Parker W. Ten Dijke P. Thorikay M. Philip A. (2008) AIL 1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes. J Bone Miner Res 23: 896–906.
48. Fioravanti A. Fabbroni M. Cerase A. Galeazzi M. (2009) Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int 29: 961–965.
49. Flechtenmacher J. Huch K. Thonar E. Mollenhauer J. Davies S. Schmid T. et al. (1996) Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes. Arthritis Rheum 39: 1896–1904.
50. Forsythe J. Jiang B. Iyer N. Agani F. Leung S. Koos R. et al. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16: 4604–4613.
51. Fortier L. Barker J. Strauss E. McCarrel T. Cole B. (2011) The role of growth factors in cartilage repair. Clin Orthop Relat Res 469: 2706–2715.
52. Frazier K. Thomas R. Scicchitano M. Mirabile R. Boyce R. Zimmerman D. et al. (2007) Inhibition of ALK 5 signaling induces physeal dysplasia in rats. Toxicol Pathol 35: 284–295.
53. Fuerst M. Bertrand J. Lammers L. Dreier R. Echtermeyer F. Nitschke Y. et al. (2009) Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum 60: 2694–2703.
54. Gelse K. Ekici A. Cipa F. Swoboda B. Carl H. Olk A. et al. (2012) Molecular differentiation between osteophytic and articular cartilage – clues for a transient and permanent chondrocyte phenotype. Osteoarthritis Cartilage 20: 162–171.
55. Geyer M. Muller-Ladner U. (2010) Actual status of antiinterleukin-1 therapies in rheumatic diseases. Curr Opin Rheumatol 22: 246–251.
56. Goldring M. (2000) Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2: 459–465.
57. Goldring M. Marcu K. (2009) Cartilage homeostasis in health and rheumatic diseases. Arthritis Res Ther 11: 224.
58. Goldring M. Otero M. (2011) Inflammation in osteoarthritis. Curr Opin Rheumatol 23: 471–478.
59. Goldring M. Suen L. Yamin R. Lai W. (1996) Regulation of collagen gene expression by prostaglandins and interleukin-1beta in cultured chondrocytes and fibroblasts. Am J Ther 3: 9–16.
60. Goumans M. Valdimarsdottir G. Itoh S. Lebrin F. Larsson J. Mummery C. et al. (2003) Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol Cell 12: 817–828.
61. Guler-Yuksel M. Allaart C. Watt I. Goekoop-Ruiterman Y. de Vries-Bouwstra J. van Schaardenburg D. et al. (2010) Treatment with TNG-alpha inhibitor infliximab might reduce hand osteoarthritis in patients with rheumatoid arthritis. Osteoarthritis Cartilage 18: 1256–1262.
62. Guo X. Wang X. (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19: 71–88.
63. Haddad J. (2002) Recombinant human interleukin (IL)-1 beta-mediated regulation of hypoxia-inducible factor-1 alpha (HIF-1 alpha) stabilization, nuclear translocation and activation requires an antioxidant / reactive oxygen species (ROS)-sensitive mechanism. Eur Cytokine Netw 13: 250–260.
64. Haddad J. Land S. (2001) A non-hypoxic, ROS-sensitive pathway mediates TNF-alpha-dependent regulation of HIF-1alpha. FEBS Lett 505: 269–274.
65. Hellingman C. Davidson E. Koevoet W. Vitters E. van Den Berg W. van Osch G. et al. (2011) Smad signaling determines chondrogenic differentiation of bone-marrow-derived mesenchymal stem cells: inhibition of Smad1/5/8p prevents terminal differentiation and calcification. Tissue Eng Part A 17: 1157–1167.
66. Hellwig-Burgel T. Rutkowski K. Metzen E. Fandrey J. Jelkmann W. (1999) Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 94: 1561–1567.
67. Henrotin Y. Kurz B. Aigner T. (2005) Oxygen and reactive oxygen species in cartilage degradation: friends or foes? Osteoarthritis Cartilage 13: 643–654.
68. Hiraide A. Yokoo N. Xin K. Okuda K. Mizukami H. Ozawa K. et al. (2005) Repair of articular cartilage defect by intraarticular administration of basic fibroblast growth factor gene, using adeno-associated virus vector. Hum Gene Ther 16: 1413–1421.
69. Honsawek S. Tanavalee A. Yuktanandana P. Ngarmukos S. Saetan N. Tantavisut S. (2010) Dickkopf-1 (Dkk-1) in plasma and synovial fluid is inversely correlated with radiographic severity of knee osteoarthritis patients. BMC Musculoskelet Disord 11: 257.
70. Huch K. Wilbrink B. Flechtenmacher J. Koepp H. Aydelotte M. Sampath T. et al. (1997) Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E2, and interleukin-1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin-1beta. Arthritis Rheum 40: 2157–2161.
71. Hunter D. Pike M. Jonas B. Kissin E. Krop J. McAlindon T. (2010) Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord 11: 232.
72. Husa M. Liu-Bryan R. Terkeltaub R. (2010) Shifting HIFs in osteoarthritis. Nat Med 16: 641–644.
73. Im H. Li X. Muddasani P. Kim G. Davis F. Rangan J. et al. (2008) Basic fibroblast growth factor accelerates matrix degradation via a neuro-endocrine pathway in human adult articular chondrocytes. J Cell Physiol 215: 452–463.
74. Im H. Muddasani P. Natarajan V. Schmid T. Block J. Davis F. et al. (2007) Basic fibroblast growth factor stimulates matrix metalloproteinase-13 via the molecular cross-talk between the mitogen-activated protein kinases and protein kinase Cδ pathways in human adult articular chondrocytes. J Biol Chem 282: 11110–11121.
75. Inoue A. Takahashi K. Arai Y. Tonomura H. Sakao K. Saito M. et al. (2006) The therapeutic effects of basic fibroblast growth factor contained in gelatin hydrogel microspheres on experimental osteoarthritis in the rabbit knee. Arthritis Rheum 54: 264–270.
76. Itasaki N. Hoppler S. (2010) Crosstalk between Wnt and bone morphogenic protein signaling: a turbulent relationship. Dev Dyn 239: 16–33.
77. Jiang D. Liang J. Fan J. Yu S. Chen S. Luo Y. et al. (2005) Regulation of lung injury and repair by toll-like receptors and hyaluronan. Nat Med 11: 1173–1179.
78. Johnson G. Brunn G. Kodaira Y. Platt J. (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4. J Immunol 168: 5233–5239.
79. Johnson K. Zhu S. Tremblay M. Payette J. Wang J. Bouchez L. et al. (2012) A stem cell-based approach to cartilage repair. Science 336: 717–721.
80. Jung Y. Isaacs J. Lee S. Trepel J. Neckers L. (2003) IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB J 17: 2115–2117.
81. Kanakaris N. Calori G. Verdonk R. Burssens P. de Biase P. Capanna R. et al. (2008) Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 39(Suppl. 2): S83–S90.
82. Kapoor M. Martel-Pelletier J. Lajeunesse D. Pelletier J. Fahmi H. (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 7: 33–42.
83. Kaul G. Cucchiarini M. Arntzen D. Zurakowski D. Menger M. Kohn D. et al. (2006) Local stimulation of articular cartilage repair by transplantation of encapsulated chondrocytes overexpressing human fibroblast growth factor 2 (FGF-2) in vivo. J Gene Med 8: 100–111.
84. Kawaguchi H. (2008) Endochondral ossification signals in cartilage degradation during osteoarthritis progression in experimental mouse models. Mol Cells 25: 1–6.
85. Kim H. Cho M. Choi H. Yoon C. Jhun J. Oh H. et al. (2006) The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis Rheum 54: 2152–2163.
86. Klatt A. Zech D. Kuhn G. Paul-Klausch B. Klinger G. Renno J. et al. (2009) Discoidin domain receptor 2 mediates the collagen II-dependent release of interleukin-6 in primary human chondrocytes. J Pathol 218: 241–247.
87. Kloppenburg M. Kwok W. (2012) Hand osteoarthritis – a heterogeneous disorder. Nat Rev Rheumatol 8: 22–31.
88. Kobayashi T. Soegiarto D. Yang Y. Lanske B. Schipani E. Mcmahon A. et al. (2005) Indian Hedgehog stimulates periarticular chondrocyte differentiation to regulate growth plate length independently of PTHRP. J Clin Invest 115: 1734–1742.
89. Koepp H. Sampath K. Kuettner K. Homandberg G. (1999) Osteogenic protein-1 (OP-1) blocks cartilage damage caused by fibronectin fragments and promotes repair by enhancing proteoglycan synthesis. Inflamm Res 48: 199–204.
90. Konig H. Kogel D. Rami A. Prehn J. (2005) TGF-{Beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J Cell Biol 168: 1077–1086.
91. Kronenberg H. (2003) Developmental regulation of the growth plate. Nature 423: 332–336.
92. Krzeski P. Buckland-Wright C. Balint G. Cline G. Stoner K. Lyon R. et al. (2007) Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther 9: R109.
93. Lane N. Nevitt M. Lui L. de Leon P. Corr M. (2007) Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum 56: 3319–3325.
94. Lanske B. Karaplis A. Lee K. Luz A. Vortkamp A. Pirro A. et al. (1996) PTH / PTHRP receptor in early development and Indian Hedgehog-regulated bone growth. Science 273: 663–666.
95. Lee K. Kim H. Li Q. Chi X. Ueta C. Komori T. et al. (2000) Runx 2 is a common target of transforming growth factor beta 1 and bone morphogenetic protein 2, and cooperation between Runx 2 and Smad 5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783–8792.
96. Le Graverand-Gastineau M. (2010) Disease modifying osteoarthritis drugs: facing development challenges and choosing molecular targets. Curr Drug Targets 11: 528–535.
97. Leong D. Hardin J. Cobelli N. Sun H. (2011) Mechanotransduction and cartilage integrity. Ann N Y Acad Sci 1240: 32–37.
98. Li J. Anemaet W. Diaz M. Buchanan S. Tortorella M. Malfait A. et al. (2011) Knockout of ADAMTS 5 does not eliminate cartilage aggrecanase activity but abrogates joint fibrosis and promotes cartilage aggrecan deposition in murine osteoarthritis models. J Orthop Res 29: 516–522.
99. Li T. Darowish M. Zuscik M. Chen D. Schwarz E. Rosier R. et al. (2006) Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J Bone Miner Res 21: 4–16.
100. Li X. Afif H. Cheng S. Martel-Pelletier J. Pelletier J. Ranger P. et al. (2005) Expression and regulation of microsomal prostaglandin e synthase-1 in human osteoarthritic cartilage and chondrocytes. J Rheumatol 32: 887–895.
101. Lin A. Seeto B. Bartoszko J. Khoury M. Whetstone H. Ho L. et al. (2009) Modulating Hedgehog signaling can attenuate the severity of osteoarthritis. Nat Med 15: 1421–1425.
102. Little C. Barai A. Burkhardt D. Smith S. Fosang A. Werb Z. et al. (2009) Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. Arthritis Rheum 60: 3723–3733.
103. Liu Z. Xu J. Colvin J. Ornitz D. (2002) Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev 16: 859–869.
104. Liu-Bryan R. Terkeltaub R. (2010) Chondrocyte innate immune myeloid differentiation factor 88-dependent signaling drives procatabolic effects of the endogenous toll-like receptor 2/toll-like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice. Arthritis Rheum 62: 2004–2012.
105. Lodewyckx L. Cailotto F. Thysen S. Luyten F. Lories R. (2012) Tight regulation of wingless-type signaling in the articular cartilage - subchondral bone biomechanical unit: transcriptomics in Frzb-knockout mice. Arthritis Res Ther 14: R16.
106. Loeser R. (2010) Age-related changes in the musculoskeletal system and the development of osteoarthritis. Clin Geriatr Med 26: 371–386.
107. Loeser R. Chubinskaya S. Pacione C. Im H. (2005) Basic fibroblast growth factor inhibits the anabolic activity of insulin-like growth factor 1 and osteogenic protein 1 in adult human articular chondrocytes. Arthritis Rheum 52: 3910–3917.
108. Loeser R. Goldring S. Scanzello C. Goldring M. (2012) Osteoarthritis: a disease of the joint as an organ. Arthritis Rheum 64: 1687–1707.
109. Logan C. Nusse R. (2004) The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol 20: 781–810.
110. Lories R. Luyten F. (2011) The bone-cartilage unit in osteoarthritis. Nat Rev Rheumatol 7: 43–49.
111. Loughlin J. Dowling B. Chapman K. Marcelline L. Mustafa Z. Southam L. et al. (2004) Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc Natl Acad Sci U S A 101: 9757–9762.
112. Mackie E. Ahmed Y. Tatarczuch L. Chen K. Mirams M. (2008) Endochondral ossification: how cartilage is converted into bone in the developing skeleton. Int J Biochem Cell Biol 40: 46–62.
113. Madry H. Kaul G. Cucchiarini M. Stein U. Zurakowski D. Remberger K. et al. (2005) Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther 12: 1171–1179.
114. Maeda Y. Nakamura E. Nguyen M. Suva L. Swain F. Razzaque M. et al. (2007) Indian Hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc Natl Acad Sci U S A 104: 6382–6387.
115. Magnano M. Chakravarty E. Broudy C. Chung L. Kelman A. Hillygus J. et al. (2007) A pilot study of tumor necrosis factor inhibition in erosive / inflammatory osteoarthritis of the hands. J Rheumatol 34: 1323–1327.
116. Mak K. Kronenberg H. Chuang P. Mackem S. Yang Y. (2008) Indian Hedgehog signals independently of PTHrP to promote chondrocyte hypertrophy. Development 135: 1947–1956.
117. Marcu K. Otero M. Olivotto E. Borzi R. Goldring M. (2010) NF-kappaB signaling: multiple angles to target OA. Curr Drug Targets 11: 599–613.
118. Masuko-Hongo K. Berenbaum F. Humbert L. Salvat C. Goldring M. Thirion S. (2004) Up-regulation of microsomal prostaglandin E synthase 1 in osteoarthritic human cartilage: critical roles of the ERK-1/2 and p 38 signaling pathways. Arthritis Rheum 50: 2829–2838.
119. Matsubara T. Kida K. Yamaguchi A. Hata K. Ichida F. Meguro H. et al. (2008) BMP 2 regulates Osterix through Msx 2 and Runx 2 during osteoblast differentiation. J Biol Chem 283: 29119–29125.
120. Matthews J. Chung M. Matyas J. (2004) Indirect injury stimulates scar formation-adaptation or pathology? Connect Tissue Res 45: 94–100.
121. Mazzetti I. Grigolo B. Pulsatelli L. Dolzani P. Silvestri T. Roseti L. et al. (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci (Lond) 101: 593–599.
122. McDermott M.F. (2009) Rilonacept in the treatment of chronic inflammatory disorders. Drugs Today (Barc) 45: 423–430.
123. Medzhitov R. (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1: 135–145.
124. Melchiorri C. Meliconi R. Frizziero L. Silvestri T. Pulsatelli L. Mazzetti I. et al. (1998) Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 41: 2165–2174.
125. Miclea R. Siebelt M. Finos L. Goeman J. Lowik C. Oostdijk W. et al. (2011) Inhibition of GSK3beta in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis Cartilage 19: 1363–1372.
126. Miyaki S. Nakasa T. Otsuki S. Grogan S. Higashiyama R. Inoue A. et al. (2009) Microrna-140 is expressed in differentiated human articular chondrocytes and modulates interleukin-1 responses. Arthritis Rheum 60: 2723–2730.
127. Mizushima N. (2009) Physiological functions of autophagy. Curr Top Microbiol Immunol 335: 71–84.
128. Mizushima N. Klionsky D. (2007) Protein turnover via autophagy: implications for metabolism. Annu Rev Nutr 27: 19–40.
129. Mobasheri A. Richardson S. Mobasheri R. Shakibaei M. Hoyland J. (2005) Hypoxia inducible factor-1 and facilitative glucose transporters GLUT 1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Histol Histopathol 20: 1327–1338.
130. Monroe D. McGee-Lawrence M. Oursler M. Westendorf J. (2012) Update on Wnt signaling in bone cell biology and bone disease. Gene 492: 1–18.
131. Moore E. Bendele A. Thompson D. Littau A. Waggie K. Reardon B. et al. (2005) Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 13: 623–631.
132. Muddasani P. Norman J. Ellman M. van Wijnen A. Im H. (2007) Basic fibroblast growth factor activates the MAPK and NFkappaB pathways that converge on Elk-1 to control production of matrix metalloproteinase-13 by human adult articular chondrocytes. J Biol Chem 282: 31409–31421.
133. Murata M. Yudoh K. Masuko K. (2008) The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage 16: 279–286.
134. Naito A. Sumida T. Nomura S. Liu M. Higo T. Nakagawa A. et al. (2012) Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes. Cell 149: 1298–1313.
135. Nalesso G. Sherwood J. Bertrand J. Pap T. Ramachandran M. de Bari C. et al. (2011) Wnt-3a modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J Cell Biol 193: 551–564.
136. Ng T. Chiu K. Rabie A. Hagg U. (2006) Repeated mechanical loading enhances the expression of Indian Hedgehog in condylar cartilage. Front Biosci 11: 943–948.
137. Nishida Y. Knudson C. Knudson W. (2004) Osteogenic protein-1 inhibits matrix depletion in a hyaluronan hexasaccharide-induced model of osteoarthritis. Osteoarthritis Cartilage 12: 374–382.
138. Nishimura R. Hata K. Matsubara T. Wakabayashi M. Yoneda T. (2012) Regulation of bone and cartilage development by network between BMP signalling and transcription factors. J Biochem 151: 247–254.
139. Notoya K. Jovanovic D. Reboul P. Martel-Pelletier J. Mineau F. Pelletier J. (2000) The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E 2 via the induction of cyclooxygenase-2. J Immunol 165: 3402–3410.
140. Okamura Y. Watari M. Jerud E. Young D. Ishizaka S. Rose J. et al. (2001) The extra domain a of fibronectin activates toll-like receptor 4. J Biol Chem 276: 10229–10233.
141. Onyekwelu I. Goldring M. Hidaka C. (2009) Chondrogenesis, joint formation, and articular cartilage regeneration. J Cell Biochem 107: 383–392.
142. Pais H. Nicolas F. Soond S. Swingler T. Clark I. Chantry A. et al. (2010) Analyzing mRNA expression identifies Smad 3 as a microRNA-140 target regulated only at protein level. RNA 16: 489–494.
143. Patel S. Simon M. (2008) Biology of hypoxia-inducible factor-2alpha in development and disease. Cell Death Differ 15: 628–634.
144. Petersen W. Varoga D. Zantop T. Hassenpflug J. Mentlein R. Pufe T. (2004) Cyclic strain influences the expression of the vascular endothelial growth factor (VEGF) and the hypoxia inducible factor 1 alpha (HIF-1alpha) in tendon fibroblasts. J Orthop Res 22: 847–853.
145. Pfander D. Cramer T. Swoboda B. (2005) Hypoxia and HIF-1alpha in osteoarthritis. Int Orthop 29: 6–9.
146. Plaas A. Velasco J. Gorski D. Li J. Cole A. Christopherson K. et al. (2011) The relationship between fibrogenic TGFbeta 1 signaling in the joint and cartilage degradation in post-injury osteoarthritis. Osteoarthritis Cartilage 19: 1081–1090.
147. Pufe T. Lemke A. Kurz B. Petersen W. Tillmann B. Grodzinsky A. et al. (2004) Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164: 185–192.
148. Rasheed Z. Akhtar N. Haqqi T. (2011) Advanced glycation end products induce the expression of interleukin-6 and interleukin-8 by receptor for advanced glycation end product-mediated activation of mitogen-activated protein kinases and nuclear factor-kappaB in human osteoarthritis chondrocytes. Rheumatology (Oxford) 50: 838–851.
149. Ratcliffe P. (2007) HIF-1 and HIF-2: working alone or together in hypoxia? J Clin Invest 117: 862–865.
150. Ricote M. Garcia-Tunon I. Bethencourt F. Fraile B. Fraile B. Paniagua R. Royuela M. (2004) Interleukin-1 (IL-1alpha and IL-1beta) and its receptors (IL-1RI, IL-1RII, and IL-1RA) in prostate carcinoma. Cancer 100: 1388–1396.
151. Ruiz-Heiland G. Horn A. Zerr P. Hofstetter W. Baum W. Stock M. et al. (2012) Blockade of the Hedgehog pathway inhibits osteophyte formation in arthritis. Ann Rheum Dis 71: 400–407.
152. Saito T. Fukai A. Mabuchi A. Ikeda T. Yano F. Ohba S. et al. (2010) Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med 16: 678–686.
153. Salminen A. Kauppinen A. Suuronen T. Kaarniranta K. Ojala J. (2009) ER stress in Alzheimer's disease: a novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation 6: 41.
154. Scharstuhl A. Vitters E. van der Kraan P. van Den Berg W. (2003) Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta / bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum 48: 3442–3451.
155. Schipani E. Ryan H. Didrickson S. Kobayashi T. Knight M. Johnson R. (2001) Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 15: 2865–2876.
156. Semenza G. (2000) HIF-1 and human disease: one highly involved factor. Genes Dev 14: 1983–1991.
157. Serra R. Johnson M. Filvaroff E. Laborde J. Sheehan D. Derynck R. et al. (1997) Expression of a truncated, kinase-defective TGF-beta type II receptor in mouse skeletal tissue promotes terminal chondrocyte differentiation and osteoarthritis. J Cell Biol 139: 541–552.
158. Shibakawa A. Aoki H. Masuko-Hongo K. Kato T. Tanaka M. Nishioka K. et al. (2003) Presence of pannus-like tissue on osteoarthritic cartilage and its histological character. Osteoarthritis Cartilage 11: 133–140.
159. Song R. Tortorella M. Malfait A. Alston J. Yang Z. Arner E. et al. (2007) Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 56: 575–585.
160. Stewart K. Pabbruwe M. Dickinson S. Sims T. Hollander A. Chaudhuri J. (2007) The effect of growth factor treatment on meniscal chondrocyte proliferation and differentiation on polyglycolic acid scaffolds. Tissue Eng 13: 271–280.
161. Stokes D. Liu G. Coimbra I. Piera-Velazquez S. Crowl R. Jimenez S. (2002) Assessment of the gene expression profile of differentiated and dedifferentiated human fetal chondrocytes by microarray analysis. Arthritis Rheum 46: 404–419.
162. Sun H. (2010) Mechanical loading, cartilage degradation, and arthritis. Ann N Y Acad Sci 1211: 37–50.
163. Symmons D. Mathers C. Pfleger B. (2002) Global burden of disease 2000. World Health Organization World Health Report 2002. Geneva: World Health Organization.
164. Tamiya H. Ikeda T. Jeong J. Saito T. Yano F. Jung Y. et al. (2008) Analysis of the Runx 2 promoter in osseous and non-osseous cells and identification of HIF2A as a potent transcription activator. Gene 416: 53–60.
165. Termeer C. Benedix F. Sleeman J. Fieber C. Voith U. Ahrens T. et al. (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195: 99–111.
166. Tkachenko E. Rhodes J. Simons M. (2005) Syndecans – new kids on the signaling block. Circ Res 96: 488–500.
167. Uchiyama Y. Shibata M. Koike M. Yoshimura K. Sasaki M. (2008) Autophagy-physiology and pathophysiology. Histochem Cell Biol 129: 407–420.
168. Urano T. Shiraki M. Narusawa K. Usui T. Sasaki N. Hosoi T. et al. (2007) Q89r polymorphism in the LDL receptor-related protein 5 gene is associated with spinal osteoarthritis in postmenopausal Japanese women. Spine (Phila Pa 1976) 32: 25–29.
169. van Beuningen H. Glansbeek H. van der Kraan P. van Den Berg W. (1998) Differential effects of local application of BMP-2 or TGF-beta 1 on both articular cartilage composition and osteophyte formation. Osteoarthritis Cartilage 6: 306–317.
170. van Beuningen H. van der Kraan P. Arntz O. van Den Berg W. (1993) Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor beta: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 52: 185–191.
171. van der Kraan P. Blaney Davidson E. van Den Berg W. (2010 a) A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis. Arthritis Res Ther 12: 201.
172. van der Kraan P. Blaney Davidson E. van Den Berg W. (2010 b) Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's? Osteoarthritis Cartilage 18: 735–741.
173. van der Kraan P. van Den Berg W. (2012) Chondrocyte hypertrophy and osteoarthritis: role in initiation and progression of cartilage degeneration? Osteoarthritis Cartilage 20: 223–232.
174. van Donkelaar C. Wilson W. (2012) Mechanics of chondrocyte hypertrophy. Biomech Model Mechanobiol 11: 655–664.
175. Velasco J. Li J. Dipietro L. Stepp M. Sandy J. Plaas A. (2011) Adamts 5 deletion blocks murine dermal repair through CD44-mediated aggrecan accumulation and modulation of transforming growth factor beta 1 (TGFbeta1) signaling. J Biol Chem 286: 26016–26027.
176. Verbruggen G. Wittoek R. Cruyssen B. Elewaut D. (2012) Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 71: 891–898.
177. von der Mark K. Kirsch T. Nerlich A. Kuss A. Weseloh G. Gluckert K. et al (1992) Type X collagen synthesis in human osteoarthritic cartilage. indication of chondrocyte hypertrophy. Arthritis Rheum 35: 806–811.
178. Vortkamp A. Lee K. Lanske B. Segre G. Kronenberg H. Tabin C. (1996) Regulation of rate of cartilage differentiation by Indian Hedgehog and PTH-related protein. Science 273: 613–622.
179. Wang G. Jiang B. Rue E. Semenza G. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-pas heterodimer regulated by cellular O 2 tension. Proc Natl Acad Sci U S A 92: 5510–5514.
180. Wang Q. Rozelle A. Lepus C. Scanzello C. Song J. Larsen D. et al. (2011) Identification of a central role for complement in osteoarthritis. Nat Med 17: 1674–1679.
181. Wang V. Davis D. Haque M. Huang L. Yarchoan R. (2005) Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res 65: 3299–3306.
182. Wei L. Kanbe K. Lee M. Wei X. Pei M. Sun X. et al. (2010) Stimulation of chondrocyte hypertrophy by chemokine stromal cell-derived factor 1 in the chondro-osseous junction during endochondral bone formation. Dev Biol 341: 236–245.
183. Wei T. Kulkarni N. Zeng Q. Helvering L. Lin X. Lawrence F. et al. (2010) Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. Osteoarthritis Cartilage 18: 992–1000.
184. Wenke A. Niebler S. Grassel S. Bosserhoff A. (2011) The transcription factor AP-2ϵ regulates CXCL 1 During cartilage development and in osteoarthritis. Osteoarthritis Cartilage 19: 206–212.
185. Wesche H. Korherr C. Kracht M. Falk W. Resch K. Martin M. (1997) The interleukin-1 receptor accessory protein (IL-1RACP) is essential for IL-1-induced activation of interleukin-1 receptor-associated kinase (IRAK) and stress-activated protein kinases (SAP kinases). J Biol Chem 272: 7727–7731.
186. Wilson C. Chuang P. (2010) Mechanism and evolution of cytosolic Hedgehog signal transduction. Development 137: 2079–2094.
187. Xu L. Peng H. Glasson S. Lee P. Hu K. Ijiri K. et al. (2007) Increased expression of the collagen receptor discoidin domain receptor 2 in articular cartilage as a key event in the pathogenesis of osteoarthritis. Arthritis Rheum 56: 2663–2673.
188. Xu L. Peng H. Wu D. Hu K. Goldring M. Olsen B. et al. (2005) Activation of the discoidin domain receptor 2 induces expression of matrix metalloproteinase 13 associated with osteoarthritis in mice. J Biol Chem 280: 548–555.
189. Xu L. Polur I. Servais J. Hsieh S. Lee P. Goldring M. et al. (2011) Intact pericellular matrix of articular cartilage is required for unactivated discoidin domain receptor 2 in the mouse model. Am J Pathol 179: 1338–1346.
190. Xu L. Servais J. Polur I. Kim D. Lee P. Chung K. et al. (2010) Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice. Arthritis Rheum 62: 2736–2744.
191. Yang S. Kim J. Ryu J. Oh H. Chun C. Kim B. et al. (2010) Hypoxia-inducible factor-2alpha is a catabolic regulator of osteoarthritic cartilage destruction. Nat Med 16: 687–693.
192. Yang X. Chen L. Xu X. Li C. Huang C. Deng C. (2001) TGF-beta/Smad3 signals repress chondrocyte hypertrophic differentiation and are required for maintaining articular cartilage. J Cell Biol 153: 35–46.
193. Yasuhara R. Ohta Y. Yuasa T. Kondo N. Hoang T. Addya S. et al. (2011) Roles of beta-catenin signaling in phenotypic expression and proliferation of articular cartilage superficial zone cells. Lab Invest 91: 1739–1752.
194. Yuan G. Tanaka M. Masuko-Hongo K. Shibakawa A. Kato T. Nishioka K. et al. (2004) Characterization of cells from pannus-like tissue over articular cartilage of advanced osteoarthritis. Osteoarthritis Cartilage 12: 38–45.
195. Yudoh K. Nakamura H. Masuko-Hongo K. Kato T. Nishioka K. (2005) Catabolic stress induces expression of hypoxia-inducible factor (HIF)-1 alpha in articular chondrocytes: involvement of HIF-1 alpha in the pathogenesis of osteoarthritis. Arthritis Res Ther 7: R904–R914.
196. Zhang Q. Hui W. Litherland G. Barter M. Davidson R. Darrah C. et al. (2008 a) Differential toll-like receptor-dependent collagenase expression in chondrocytes. Ann Rheum Dis 67: 1633–1641.
197. Zhang W. Moskowitz R. Nuki G. Abramson S. Altman R. Arden N. et al. (2008 b) OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16: 137–162.
198. Zhang Y. Su J. Yu J. Bu X. Ren T. Liu X. et al. (2011) An essential role of discoidin domain receptor 2 (DDR2) in osteoblast differentiation and chondrocyte maturation via modulation of RUNX 2 activation. J Bone Miner Res 26: 604–617.
199. Zhang Z. Schluesener H. (2006) Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell Mol Life Sci 63: 2901–2907.
200. Zhu M. Tang D. Wu Q. Hao S. Chen M. Xie C. et al. (2009) Activation of beta-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult beta-catenin conditional activation mice. J Bone Miner Res 24: 12–21.